GECO Stock Overview
GENETICO PJSC provides genetic diagnostics for hereditary diseases and reproductive disorders. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
GENETICO PJSC Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₽17.88 |
52 Week High | ₽0 |
52 Week Low | ₽0 |
Beta | 0 |
1 Month Change | n/a |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 0% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
GECO | RU Healthcare | RU Market | |
---|---|---|---|
7D | n/a | -2.7% | -2.8% |
1Y | n/a | 1.9% | 1.4% |
Return vs Industry: Insufficient data to determine how GECO performed against the Russian Healthcare industry.
Return vs Market: Insufficient data to determine how GECO performed against the Russian Market.
Price Volatility
GECO volatility | |
---|---|
GECO Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 4.2% |
Market Average Movement | 4.5% |
10% most volatile stocks in RU Market | 9.8% |
10% least volatile stocks in RU Market | 2.4% |
Stable Share Price: GECO has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine GECO's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | n/a | genetico.ru |
GENETICO PJSC provides genetic diagnostics for hereditary diseases and reproductive disorders. The company offers whole-genome and whole-exome sequencing, as well as preimplantation genetic testing for chromosomal abnormalities; and non-invasive prenatal testing services. It also provides consultation services.
GENETICO PJSC Fundamentals Summary
GECO fundamental statistics | |
---|---|
Market cap | n/a |
Earnings (TTM) | -₽116.29m |
Revenue (TTM) | ₽407.29m |
0.0x
P/S Ratio0.0x
P/E RatioIs GECO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
GECO income statement (TTM) | |
---|---|
Revenue | ₽407.29m |
Cost of Revenue | ₽352.67m |
Gross Profit | ₽54.63m |
Other Expenses | ₽170.92m |
Earnings | -₽116.29m |
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did GECO perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2023/04/27 15:49 |
End of Day Share Price | 2023/04/24 00:00 |
Earnings | 2021/09/30 |
Annual Earnings | 2020/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
GENETICO PJSC is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|